Target Name: SEPTIN6
NCBI ID: G23157
Review Report on SEPTIN6 Target / Biomarker Content of Review Report on SEPTIN6 Target / Biomarker
SEPTIN6
Other Name(s): SEPT2 | KIAA0128 | Septin-6 (isoform A) | Septin 6, transcript variant I | Septin-6 | RP5-876A24.2 | MGC16619 | septin 6 | SEPT6 | SEPTIN6 variant I | Septin-6 (isoform B) | SEP2 | Septin 2 | OTTHUMP00000023918 | OTTHUMP00000023921 | SEPTIN6 variant II | Septin 6, transcript variant II | SEPT6_HUMAN | septin 2 | MGC20339 | OTTHUMP00000023916

SEPTIN6: A Protein Involved in Cytoskeleton and Cell Division

SEPTIN6 (SEPT2) is a protein that is expressed in most tissues of the body. It is a key component of the cytoskeleton and is involved in the organization of cells and tissues. SEPTIN6 has also been shown to play a role in the regulation of cell division and has been linked to the development and progression of various diseases. As a result, SEPTIN6 has potential as a drug target or biomarker.

The cytoskeleton is a complex structure that is essential for the proper functioning of many cells and tissues. It is a framework that helps maintain the shape and stability of cells and allows them to move and function properly. The cytoskeleton is made up of a variety of proteins, including SEPTIN6. This protein helps to keep the cytoskeleton organized and structured, and it is involved in the regulation of cell division.

SEPTIN6 is a key component of the cytoskeleton because it helps to keep the cell's center of gravity in the center of the cell. This is important for the proper functioning of the cell and is necessary for the cell to be able to move and function properly. SEPTIN6 is also involved in the organization of the cytoskeleton and helps to keep it stable.

In addition to its role in the cytoskeleton, SEPTIN6 has also been shown to play a role in the regulation of cell division. It has been shown to be involved in the formation of the replication complex, which is the group of proteins that help to replicate the DNA in a cell. SEPTIN6 has also been shown to be involved in the regulation of the G1/S transition, which is the stage of cell division where a cell prepares for cell division by producing more DNA.

SEPTIN6 has also been linked to the development and progression of various diseases. For example, studies have shown that SEPTIN6 is often reduced in the tissues of people with cancer. This suggests that it may be an important biomarker for cancer and could be a potential target for cancer therapies. In addition, SEPTIN6 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. This suggests that it may be an important target for these diseases as well.

As a result of its role in the cytoskeleton and its potential involvement in the regulation of cell division, SEPTIN6 has generated a lot of interest as a drug target or biomarker. Studies are being conducted to determine the effects of drugs on SEPTIN6 and to understand its potential as a therapeutic agent. In addition, researchers are also working to develop SEPTIN6-based diagnostics to use in the clinic.

In conclusion, SEPTIN6 is a protein that is expressed in most tissues of the body and plays a key role in the cytoskeleton. It is also involved in the regulation of cell division and has been linked to the development and progression of various diseases. As a result, SEPTIN6 has potential as a drug target or biomarker and is an important area of research in the field of cellular biology.

Protein Name: Septin 6

Functions: Filament-forming cytoskeletal GTPase. Required for normal organization of the actin cytoskeleton. Involved in cytokinesis. May play a role in HCV RNA replication. Forms a filamentous structure with SEPTIN12, SEPTIN6, SEPTIN2 and probably SEPTIN4 at the sperm annulus which is required for the structural integrity and motility of the sperm tail during postmeiotic differentiation (PubMed:25588830)

The "SEPTIN6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEPTIN6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4 | SERTAD4-AS1 | SERTM1 | SERTM2 | Serum amyloid protein | SESN1 | SESN2 | SESN3 | SESTD1 | Sestrin | SET | SET1 histone methyltransferase complex | SETBP1 | SETBP1-DT | SETD1A | SETD1B | SETD2 | SETD3 | SETD4 | SETD4-AS1 | SETD5 | SETD6 | SETD7 | SETD9 | SETDB1 | SETDB2 | SETMAR | SETP14 | SETP20